These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16395996)

  • 21. On non-inferiority margin and statistical tests in active control trials.
    Chow SC; Shao J
    Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance.
    Parienti JJ; Verdon R; Massari V
    BMC Med Res Methodol; 2006 Sep; 6():46. PubMed ID: 16987409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
    Rousson V; Seifert B
    Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the equivalence approach in reproductive health clinical trials.
    Piaggio G; Pinol AP
    Stat Med; 2001 Dec; 20(23):3571-7. PubMed ID: 11746338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing equivalence or non-inferiority in clinical trials: part 20 of a series on evaluation of scientific publications.
    Wellek S; Blettner M
    Dtsch Arztebl Int; 2012 Oct; 109(41):674-9. PubMed ID: 23264808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.
    Laster LL; Johnson MF; Kotler ML
    Stat Med; 2006 Apr; 25(7):1115-30. PubMed ID: 16381070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of putative placebo in active control trials: two applications in a regulatory setting.
    Durrleman S; Chaikin P
    Stat Med; 2003 Mar; 22(6):941-52. PubMed ID: 12627411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dealing with discreteness: making 'exact' confidence intervals for proportions, differences of proportions, and odds ratios more exact.
    Agresti A
    Stat Methods Med Res; 2003 Jan; 12(1):3-21. PubMed ID: 12617505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.
    Althunian TA; de Boer A; Klungel OH; Insani WN; Groenwold RH
    Trials; 2017 Mar; 18(1):107. PubMed ID: 28270184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical issues in equivalence trials.
    Ebbutt AF; Frith L
    Stat Med; 1998 Aug 15-30; 17(15-16):1691-701. PubMed ID: 9749440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biostatistical assessment of mutagenicity studies by including the positive control.
    Hauschke D; Slacik-Erben R; Hensen S; Kaufmann R
    Biom J; 2005 Feb; 47(1):82-7; discussion 99-107. PubMed ID: 16395999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing superiority at interim analyses in a non-inferiority trial.
    Chen YH; Chen C
    Stat Med; 2012 Jul; 31(15):1531-42. PubMed ID: 22438208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test non-inferiority (and equivalence) based on the odds ratio under a simple crossover trial.
    Lui KJ; Chang KC
    Stat Med; 2011 May; 30(11):1230-42. PubMed ID: 21538451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes.
    Turner RM; Clements MN; Quartagno M; Cornelius V; Cro S; Ford D; Tweed CD; Walker AS; White IR
    Stat Med; 2023 Apr; 42(8):1127-1138. PubMed ID: 36661242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.